152 related articles for article (PubMed ID: 11041503)
1. Tilmicosin does not inhibit interleukin-8 gene expression in the bovine lung experimentally infected with Mannheimia (Pasteurella) haemolytica.
Goubau S; Morck DW; Buret A
Can J Vet Res; 2000 Oct; 64(4):238-42. PubMed ID: 11041503
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory benefits of tilmicosin in calves with Pasteurella haemolytica-infected lungs.
Chin AC; Morck DW; Merrill JK; Ceri H; Olson ME; Read RR; Dick P; Buret AG
Am J Vet Res; 1998 Jun; 59(6):765-71. PubMed ID: 9622749
[TBL] [Abstract][Full Text] [Related]
3. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Pasteurella haemolytica from cattle.
Stephens CP; Blackall PJ; Wade LK; Lowe LB
Aust Vet J; 1993 Oct; 70(10):391-2. PubMed ID: 8257321
[No Abstract] [Full Text] [Related]
4. Treatment of experimentally induced pneumonic pasteurellosis of young calves with tilmicosin.
Morck DW; Merrill JK; Gard MS; Olson ME; Nation PN
Can J Vet Res; 1997 Jul; 61(3):187-92. PubMed ID: 9242998
[TBL] [Abstract][Full Text] [Related]
5. Tilmicosin induces apoptosis in bovine peripheral neutrophils in the presence or in the absence of Pasteurella haemolytica and promotes neutrophil phagocytosis by macrophages.
Chin AC; Lee WD; Murrin KA; Morck DW; Merrill JK; Dick P; Buret AG
Antimicrob Agents Chemother; 2000 Sep; 44(9):2465-70. PubMed ID: 10952596
[TBL] [Abstract][Full Text] [Related]
6. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
[TBL] [Abstract][Full Text] [Related]
7. The effects of danofloxacin and tilmicosin on neutrophil function and lung consolidation in beef heifer calves with induced Pasteurella (Mannheimia) haemolytica pneumonia.
Fajt VR; Apley MD; Roth JA; Frank DE; Brogden KA; Skogerboe TL; Shostrom VK; Chin YL
J Vet Pharmacol Ther; 2003 Jun; 26(3):173-9. PubMed ID: 12755900
[TBL] [Abstract][Full Text] [Related]
8. Effect of a new macrolide antibiotic (tilmicosin) on pneumonia experimentally induced in calves by Mycoplasma bovis and Pasteurella haemolytica.
Gourlay RN; Thomas LH; Wyld SG; Smith CJ
Res Vet Sci; 1989 Jul; 47(1):84-9. PubMed ID: 2772410
[TBL] [Abstract][Full Text] [Related]
9. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease.
Shryock TR; White DW; Staples JM; Werner CS
J Vet Diagn Invest; 1996 Jul; 8(3):337-44. PubMed ID: 8844577
[TBL] [Abstract][Full Text] [Related]
10. Comparison between the minimal inhibitory concentration of tilmicosin and oxytetracycline for bovine pneumonic Pasteurella haemolytica isolates.
Hartman EG; Geryl J
Vet Q; 1993 Dec; 15(4):184. PubMed ID: 8122359
[TBL] [Abstract][Full Text] [Related]
11. Tilmicosin-induced bovine neutrophil apoptosis is cell-specific and downregulates spontaneous LTB4 synthesis without increasing Fas expression.
Lee WD; Flynn AN; LeBlanc JM; Merrill JK; Dick P; Morck DW; Buret AG
Vet Res; 2004; 35(2):213-24. PubMed ID: 15099497
[TBL] [Abstract][Full Text] [Related]
12. Treatment of calf pneumonia with tilmicosin.
Fodor L; Varga J; Gallowitsch F; Horváth-Papp I; Miklós G; Lajcsák A; Harmath A
Acta Vet Hung; 1993; 41(1-2):41-9. PubMed ID: 8116500
[TBL] [Abstract][Full Text] [Related]
13. Effects of tilmicosin treatment on Pasteurella haemolytica organisms in nasal secretion specimens of calves with respiratory tract disease.
Frank GH; Briggs RE; Loan RW; Purdy CW; Zehr ES
Am J Vet Res; 2000 May; 61(5):525-9. PubMed ID: 10803647
[TBL] [Abstract][Full Text] [Related]
14. Proposed quality control guidelines for antimicrobial susceptibility tests using tilmicosin.
Shryock TR; White DW; Werner CS; Staples JM
J Clin Microbiol; 1995 Feb; 33(2):331-5. PubMed ID: 7714188
[TBL] [Abstract][Full Text] [Related]
15. Effect of tilmicosin on chemotactic, phagocytic, and bactericidal activities of bovine and porcine alveolar macrophages.
Brumbaugh GW; Herman JD; Clancy JS; Burden KI; Barry T; Simpson RB; López HS
Am J Vet Res; 2002 Jan; 63(1):36-41. PubMed ID: 16206777
[TBL] [Abstract][Full Text] [Related]
16. A review of the toxicology of the antibiotic MICOTIL 300.
Jordan WH; Byrd RA; Cochrane RL; Hanasono GK; Hoyt JA; Main BW; Meyerhoff RD; Sarazan RD
Vet Hum Toxicol; 1993 Apr; 35(2):151-8. PubMed ID: 8470360
[TBL] [Abstract][Full Text] [Related]
17. Effect of danofloxacin and tilmicosin on body temperatures of beef calves with pneumonia experimentally induced by inoculation with Mannheimia haemolytica.
Fajt VR; Apley MD; Brogden KA; Skogerboe TL; Shostrom VK; Chin YL
Am J Vet Res; 2004 May; 65(5):610-5. PubMed ID: 15141881
[TBL] [Abstract][Full Text] [Related]
18. Use of TUNEL staining to detect apoptotic cells in the lungs of cattle experimentally infected with Pasteurella haemolytica.
Leite F; Malazdrewich C; Yoo HS; Maheswaran SK; Czuprynski CJ
Microb Pathog; 1999 Sep; 27(3):179-85. PubMed ID: 10455008
[TBL] [Abstract][Full Text] [Related]
19. Increased MICs of gamithromycin and tildipirosin in the presence of the genes erm(42) and msr(E)-mph(E) for bovine Pasteurella multocida and Mannheimia haemolytica.
Michael GB; Eidam C; Kadlec K; Meyer K; Sweeney MT; Murray RW; Watts JL; Schwarz S
J Antimicrob Chemother; 2012 Jun; 67(6):1555-7. PubMed ID: 22398653
[No Abstract] [Full Text] [Related]
20. Efficacy of difloxacin in calves experimentally infected with Mannheimia haemolytica.
Olchowy TW; TerHune TN; Herrick RL
Am J Vet Res; 2000 Jun; 61(6):710-3. PubMed ID: 10850850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
